|
|
|
OGN's Net Income Growth by Quarter and Year
Organon And Co 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| OGN Net Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
202.00
|
0.00
|
0.00
|
| III Quarter |
September |
227.00
|
323.00
|
0.00
|
0.00
|
| II Quarter |
June |
234.00
|
427.00
|
0.00
|
0.00
|
| I Quarter |
March |
348.00
|
399.00
|
0.00
|
0.00
|
| FY |
|
809.00
|
1,351.00
|
0.00
|
0.00
|
| OGN Net Income third quarter 2022 Y/Y Growth Comment |
Organon And Co reported fall in Net Income in the third quarter 2022 by -29.72% to $ 227.00 millions, from the same quarter in 2021.
The drop in the third quarter 2022 Organon And Co 's Net Income compares unfavorably to the Company's average Net Income decrease of -9.1%.
Looking into third quarter 2022 results within Major Pharmaceutical Preparations industry 38 other companies have achieved higher Net Income growth. While Organon And Co ' s Net Income drop of -29.72% ranks overall at the positon no. 1451 in the third quarter 2022.
|
| OGN Net Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
-29.72 % |
- |
- |
- |
| II Quarter |
June |
-45.2 % |
- |
- |
- |
| I Quarter |
March |
-12.78 % |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
OGN Net Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-37.46 % |
- |
- |
| III Quarter |
September |
-2.99 % |
-24.36 % |
- |
- |
| II Quarter |
June |
-32.76 % |
7.02 % |
- |
- |
| I Quarter |
March |
72.28 % |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| -3.77 % |
-9.1 % |
-14.85 % |
|
|
(Jun 30 2022) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| -3.77 % |
-9.1 % |
-14.85 % |
|
|
(Jun 30 2022) |
|
| Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Organon And Co 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 72.28 % |
-3.05 % |
-37.46 % |
| (Mar 31 2022) |
|
|
| OGN's III. Quarter Q/Q Net Income Comment |
In the III. Quarter 2022 Organon And Co realized fall in Net Income from the second quarter by -2.99% to $ 227.00 millions, from $ 234.00 millions declared a quarter before.
When you analyse recent shortcoming in the quarter, you must presume, that commonly III. Quarter Net Income appear to be weaker in contrast to the preciding period, Mia Wright, Healthcare sector contributor said.
Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income quarter on quarter growth. While Organon And Co 's Net Income growth quarter on quarter, overall rank is 1004. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 72.28 % |
-3.05 % |
-37.46 % |
| (Mar 31 2022) |
|
|
| OGN's III. Quarter Q/Q Net Income Comment |
In the III. Quarter 2022 Organon And Co reported fall in Net Income from the second quarter by -2.99% to $ 227.00 millions, from $ 234.00 millions released in the previous quarter.
If you evaluate current slump in the III. Quarter 2022, you should take into consideration, that frequently III. Quarter performance emerge softer in contrast to the second quarter
Within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Net Income quarter on quarter growth. While Organon And Co 's Net Income growth quarter on quarter, overall rank is 1004. |
|
Organon And Co 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
| Cumulative Net Income 12 Months Ending |
$ 1,011.00 |
$ 1,107.00 |
$ 1,300.00 |
$ 1,351.00 |
$ 0.00 |
| Y / Y Net Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Net Income Growth Overall
Ranking |
| | |
